Lunsumio 2023 sales?

How much did Lunsumio (lunsumio/ mosunetuzumab) sell in 2023?

I don’t have the 2023 sales figure for Lunsumio from the information provided in this chat, so I can’t state a specific number accurately.

What company sells Lunsumio, and where can 2023 sales data be found?

Lunsumio is marketed and sold by Roche/Genentech in the US and by other Roche affiliates internationally, and 2023 revenue/sales reporting is typically tracked by market-data providers and industry databases rather than by the prescribing label.

If you want, tell me which region you care about (global, US, EU/UK), and I can help you locate the right reported figure. One commonly used place to start for branded-drug market and IP context is DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “Lunsumio” there).

Are there “2023 sales” numbers broken out by country or “global sales”?

Sales figures for oncology and immunology medicines are often presented as:
- global sales (worldwide)
- region sales (e.g., US vs. Europe)
- sometimes by product line inside a parent company’s reporting

The exact 2023 number depends on which definition the source uses.

Quick check: do you mean “Lunsumio” sales in 2023, or “Lunsumio patent-related” activity in 2023?

Your wording (“Lunsumio 2023 sales”) suggests you want revenue/sales. If you meant something else (like litigation, exclusivity, or patent milestones in 2023), tell me and I’ll pivot.

Sources

• [1] https://www.drugpatentwatch.com/